SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GTC Biotherapeutics
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: DewDiligence_on_SI1/13/2008 8:03:49 PM
   of 135
 
GTCB ‘ReadMeFirst’ updated:

[Updates on various subjects: musings on non-inferiority
delta of US ATryn trial; LFB collaboration in Factor IX;
MoA of AT-heparin binding; new speculation on the US
ATryn partner; musings on the US ATryn price; new info
on size of sepsis market; value of GTC’s NOL’s; musings
on a hostile takeover; new antithrombin abstracts.]

siliconinvestor.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News